ORIC Pharmaceuticals, Inc.
NASDAQ: ORIC0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Select
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Jacob Chacko
- Employees
- 122
- Headquarters
- South San Francisco, United States
- IPO year
- 2020
- Market cap
- $976.2M
- Website
- https://www.oricpharma.com
Loading ORIC…
Loading profile data…Frequently asked questions about ORIC
What does ORIC Pharmaceuticals, Inc. (ORIC) do?
ORIC Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical firm dedicated to discovering and advancing innovative treatments for cancer patients across the United States. The company's pipeline includes several key clinical-stage drug candidates. ORIC-533 is an oral small molecule designed to inhibit CD73, addressing resistance to...
Where does ORIC trade?
ORIC Pharmaceuticals, Inc. (ORIC) trades on the NASDAQ Global Select.
What sector is ORIC in?
ORIC Pharmaceuticals, Inc. (ORIC) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of ORIC Pharmaceuticals, Inc.?
Jacob Chacko is the chief executive officer of ORIC Pharmaceuticals, Inc. (ORIC).
Where is ORIC Pharmaceuticals, Inc. headquartered?
ORIC Pharmaceuticals, Inc. is headquartered in United States.
Does ORIC pay a dividend?
ORIC Pharmaceuticals, Inc. (ORIC) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did ORIC go public?
ORIC Pharmaceuticals, Inc. (ORIC) completed its initial public offering in 2020.